ABSTRACT
We utilized the approach of stably expressing different dopamine (DA) receptors into identified cell lines in an attempt to better understand the coupling of these receptors to membrane ion channels via second messenger systems. Recently, we examined the N18TG2 x mesencephalon (MES-23.5) cell line that is phenotypically similar to mesencephalic dopamine-containing neurons. Whole-cell voltage-clamp methods were used to investigate a voltage-dependent K+ current present in these cells. Untransfected MES-23.5 cells displayed a voltage-dependent slow-onset, slowly inactivating outward current which was not altered by bath application of either the D2 DA receptor agonist quinpirole (QUIN; 10-100 microM) or the D1 DA receptor agonist SKF38393, indicating that these cells were devoid of DA receptors. The K+ current studied was activated upon depolarization from a holding potential of -60 mV to a level more positive than -20 mV and was observed to be sensitive to bath application of tetraethylammonium. When MES-23.5 cells were transfected to stably express the D2S, D2L, D3, and D4 receptors, the same current was observed. In cells expressing D2L, D2S, and D3 receptors, application of the DA receptor agonists QUIN (1-80 microM), 7-hydroxy-dipropylaminoteralin (7-OH-DPAT, 1-80 microM), and dopamine (DA, 1-80 microM), increased the peak outward current by 35-40%. In marked contrast, cells stably expressing the D4 receptor demonstrated a significant DA agonist-induced reduction of the peak K+ current by 40%. For all four receptor subtypes, the D2-like receptor antagonist sulpiride (SUL 5 microM), when coapplied with QUIN (10 microM), totally abolished the change in K+ current normally observed, while coapplication of the D1-like receptor antagonist SCH23390 was without effect. The modulation of K+ current by D2L, D3, and D4 receptor stimulation was prevented by pretreatment of the cells with pertussis toxin (PTX, 500 ng/ml for 4 h). In addition, the intracellular application of a polyclonal antibody which specifically recognizes Goalpha completely blocked the ability of D2L, D3, and D4 receptors to modulate outward K+ currents. In contrast, the intracellular application of an antibody directed against Goalpha was without effect, whereas intracellular application of an antibody recognizing Gsalpha abolished the ability of the D2S receptor to enhance K+ current. These findings demonstrate that different members of the D2 DA receptor family may couple in a given cell to a common effector in dramatically different ways.
Subject(s)
Dopamine Agonists/pharmacology , GTP-Binding Proteins/drug effects , Potassium Channels/drug effects , Receptors, Dopamine/drug effects , Animals , Autoreceptors/drug effects , Autoreceptors/physiology , Cell Line, Transformed , Cricetinae , GTP-Binding Proteins/physiology , Membrane Potentials/drug effects , Mesencephalon/drug effects , Mesencephalon/physiology , Patch-Clamp Techniques , Potassium Channels/physiology , Rats , Receptors, Dopamine/physiologyABSTRACT
The D2-like dopamine (DA) receptor family has continued to expand and now includes the D2-short (D2S) and D2-long (D2L) receptor isoforms and the D3 and D4 receptors. The D2 receptor isoforms differ in length by 29 amino acids within the third cytoplasmic loop, a region of the receptor believed to be important for G protein coupling. This observation has led to the hypothesis that the two isoforms of the D2 receptor may utilize different signal transduction pathways when present in the same cell. The D2 and D3 receptors, although mostly different, show some common amino acid sequences within the third cytoplasmic loop. Thus, it is possible that the D2 and D3 receptors may employ similar signal transduction pathways. To test these hypotheses directly, NG108-15 neuroblastoma-glioma hybrid cells were stably transfected to express either the D2S, D2L, or D3 DA receptors. All transfected but not untransfected NG108-15 cells demonstrated a dose-dependent reduction in the peak whole-cell potassium (K+) current in response to receptor activation by DA or the DA receptor agonists quinpirole (QUIN) and apomorphine (APO). The modulation of K+ current by D2S receptor stimulation was prevented by pretreatment of the cells with cholera toxin (20 micrograms/ml for 18 h), whereas pertussis toxin pretreatment (500 ng/ml for 4 h) completely blocked the effects of D2L and D3 receptor activation. These observations suggest that the signal transduction mechanisms involved in coupling the two isoforms of the D2 receptor to the K+ current are different, whereas the D2L and D3 receptor coupling mechanisms may be similar. In direct support of this hypothesis, it was observed that the intracellular application of a polyclonal antibody that is specific for the GO alpha subunit completely blocked the ability of D2L and D3 receptors to modulate outward K+ currents. In contrast, the D2S-mediated modulation of K+ currents was blocked by intracellular application of an antibody recognizing GS alpha but not GO alpha. These findings demonstrate that D2S and D2L receptors are able to couple to a common effector in a cell via two G protein pathways.
Subject(s)
GTP-Binding Proteins/physiology , Membrane Potentials/drug effects , Potassium Channels/drug effects , Quinpirole/pharmacology , Receptors, Dopamine/drug effects , Receptors, Dopamine/physiology , Animals , Dose-Response Relationship, Drug , Rats , TransfectionABSTRACT
Extracellular recording techniques were used to study antidromically activated nigrostriatal (NSDA) and mesoaccumbens (MADA) dopamine neurons in chloral hydrate-anesthetized rats. Repeated 14-day i.p. treatment with the dopamine D2-like receptor agonists, quinpirole (2 mg/kg/day) or EMD 23448 (2.6 mg/kg/day), resulted in a significant decrease in the average potency and efficacy of i.v. quinpirole (cumulative doses administered on day 15) to inhibit the spontaneous activity of NSDA neurons relative to vehicle controls. Repeated 14-day quinpirole treatment caused a significantly greater decrease in the sensitivity of MADA neurons to i.v. quinpirole challenges than NSDA neurons. When the effects on NSDA neurons were examined after a shorter treatment period, the decrease in the average potency and efficacy of i.v. quinpirole appeared to occur after only 2 days of i.p. quinpirole treatment (2 mg/kg/day). Iontophoretic studies, however, indicated that the average dopamine sensitivity of somatodendritic dopamine autoreceptors on MADA neurons, but not NSDA neurons, was significantly lower relative to controls after 14-day quinpirole treatment (2 mg/kg/day). These results suggest that this quinpirole treatment regimen can differentially affect the average sensitivity of somatodendritic dopamine autoreceptors on MADA and NSDA neurons. The somatodendritic autoreceptors on MADA neurons appear to be more sensitive to the effects of repeated 14-day quinpirole treatment than those on NSDA neurons.
Subject(s)
Dopamine Agonists/pharmacology , Dopamine/physiology , Ergolines/pharmacology , Neurons/drug effects , Nucleus Accumbens/drug effects , Receptors, Dopamine D2/agonists , Substantia Nigra/drug effects , Animals , Dopamine/pharmacology , Indoles/pharmacology , Iontophoresis , Male , Neurons/ultrastructure , Nucleus Accumbens/cytology , Quinpirole , Rats , Rats, Sprague-Dawley , Sensitivity and Specificity , Stimulation, Chemical , Substantia Nigra/cytologyABSTRACT
The sensitivity of dopamine (DA) receptors in the mesoaccumbens DA system was investigated with extracellular recording and microiontophoresis techniques in adult rats that received prenatal ethanol exposure and chronic postnatal amphetamine treatment. Pregnant rats were fed with a liquid diet containing 0 or 35% ethanol-derived calories from gestation day 6 to 20. An ad libitum group received laboratory chow and water. Offspring were injected with amphetamine (2 mg/kg/day s.c.) or saline from postnatal day 22 to 10- to 12-months of age. Electrophysiological recording procedures were performed 16 to 24 hr after the last amphetamine injection. A supersensitivity of somatodendritic DA autoreceptors in the ventral tegmental area was observed in animals exposed prenatally to ethanol. This prenatal ethanol exposure-induced supersensitivity was not observed after postnatal amphetamine treatment. In control animals, postnatal amphetamine treatment did not affect the sensitivity of somatodendritic DA autoreceptors. The sensitivity of D-1 DA receptors in the nucleus accumbens was reduced by prenatal ethanol exposure. Postnatal amphetamine treatment reduced D-1 DA receptor sensitivity in control animals, but not in animals exposed prenatally to ethanol. Neither prenatal ethanol treatment nor postnatal amphetamine treatment altered the sensitivity of D-2 DA receptors in the nucleus accumbens. There were no differences between the ad libitum and 0% ethanol-derived calorie groups, indicating undernutrition did not affect DA receptor function. These results show that prenatal ethanol exposure altered DA receptor function in the mesoaccumbens DA system in adult animals. Furthermore, postnatal amphetamine treatment was able to eliminate the supersensitivity of somatodendritic DA autoreceptors in prenatal ethanol-exposed animals.
Subject(s)
Amphetamines/pharmacology , Ethanol/pharmacology , Prenatal Exposure Delayed Effects , Receptors, Dopamine D1/drug effects , Receptors, Dopamine D2/drug effects , Ventral Tegmental Area/drug effects , Animals , Female , Male , Pregnancy , Rats , Ventral Tegmental Area/physiologyABSTRACT
Chronic infusions of brain-derived neurotrophic factor (BDNF) immediately above the substantia nigra augment spontaneous locomotion, rotational behavior, and striatal dopamine (DA) turnover, indicating that BDNF increases functions of the nigrostriatal DA system. Because the function of the nigrostriatal DA system is related to the electrical activity of DA neurons, we investigated the effect of BDNF on the electrical activity of DA neurons in the substantia nigra pars compacta in vivo. Chronic supranigral infusions of BDNF (12 micrograms/day), nerve growth factor (11 micrograms/day), or phosphate-buffered saline were started 2 weeks before the electrophysiological recordings. BDNF increased the number of spontaneously active DA neurons by 65-98%, increased the average firing rage by 32%, and increased the number of action potentials contained within bursts. Neither nerve growth factor nor phosphate-buffered saline infusions altered any of these properties relative to unoperated animals. In addition, extremely fast-firing DA neurons (> 10 spikes per sec) were commonly found only in the BDNF-infused animals. These results demonstrate neurotrophin effects on the electrical activity of intact central nervous system neurons in vivo and suggest that the increases in locomotor behavior and striatal dopamine turnover obtained during supranigral BDNF infusions may result from increases in the electrical activity of DA neurons.
Subject(s)
Dopamine/physiology , Nerve Tissue Proteins/pharmacology , Substantia Nigra/physiology , Action Potentials/drug effects , Animals , Body Weight/drug effects , Brain-Derived Neurotrophic Factor , Male , Nerve Growth Factors/pharmacology , Rats , Rats, Sprague-DawleyABSTRACT
Dopamine neurons derived from the mesencephalon of embryonic rats were maintained in primary culture, identified and studied with whole-cell patch recording techniques. These neurons demonstrated a rapidly activating and inactivating voltage-dependent outward current which required the presence of K+ ions. This current was termed IA because of its transient nature. It was elicited by step depolarizations from holding potentials more negative than -50 mV and exhibited steady-state inactivation at a membrane potential more positive than -40 mV and half-maximal inactivation observed at -65 mV. This current rapidly achieved peak activation in less than 8 msec and decayed with a time constant (tau) of 58 +/- 5 msec. This current was observed in the presence of tetraethylammonium but was readily blocked by 4-aminopyridine (2-4 mM). This current was also observed to be modulated by stimulation of D2 dopamine receptors (DA autoreceptors) located on the dopamine neurons. Thus, both DA and the D2 receptor agonist quinpirole enhanced the peak IA observed, while the partial D1 receptor agonist SKF 38393 was without effect. The enhancement of IA was confirmed to be due to the activation of D2 receptors as the effects of either DA or quinpirole were blocked by the D2 receptor antagonists eticlopride and sulpiride, but not by the D1 receptor antagonist SCH 23390. Since we have previously demonstrated that the IK present in these cells is also enhanced by D2 receptor stimulation, we investigated the signal transduction pathways involved in coupling DA autoreceptors to both IA and IK. The response of both these potassium currents to DA autoreceptor stimulation was completely abolished by the preincubation of cultures with pertussis toxin, indicating the possible involvement of the G proteins Gi and G(o). In an attempt to further characterize which G protein may be involved, additional experiments were performed. The ability of DA autoreceptor stimulation to augment both currents was also blocked completely when G protein activation was prevented by the intracellular application of GDP beta S (100 microM). In contrast, irreversible activation of G proteins by intracellular application of the nonhydrolyzable GTP analog GTP gamma S (100 microM) mimicked the effects of DA autoreceptor stimulation on both IA and IK. In addition, the intracellular application of a polyclonal antibody that was selective for the alpha-subunit of G(o) completely abolished the DA autoreceptor modulation of both currents while preimmune serum was without effect.(ABSTRACT TRUNCATED AT 400 WORDS)
Subject(s)
Dopamine/physiology , Neurons/physiology , Potassium/physiology , Signal Transduction , Animals , Autoreceptors/physiology , Electrophysiology , Rats , Receptors, Dopamine/physiology , Stimulation, ChemicalABSTRACT
In vivo electrophysiological recording methods were used to evaluate the effects of selective and nonselective agonists for excitatory amino acid (EAA) receptor subtypes on the activity of dopaminergic (DA) and nondopaminergic (non-DA) neurons in the substantia nigra of chloral hydrate-anesthetized rats. Microiontophoretic administration of (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA), 2-carboxy-4-(1-methyl-ethenyl)-3-pyrrolidinacetate (kainate), N-methyl-D-aspartate (NMDA) and glutamate excited neurons with an apparent rank order of potency of AMPA = kainate = glutamate > NMDA on DA neurons, and AMPA = kainate > glutamate = NMDA on non-DA neurons. These agonists also changed the firing pattern of DA neurons, which displayed an increase in burst-firing and a reduction in the regularity of the firing pattern. Regularity of firing was indexed by the variation coefficient of a sample of interspike intervals. The apparent potencies of the four agonists to increase burst-firing and variation coefficient were similar to their potencies to increase neuronal firing rate. Blockade of NMDA receptor function by coiontophoresis of 5R,10S-(+/-)-5-methyl-10,11-dihydro-5H-dibenzo[and]cyclohepten-5,1 0-imine hydrogen maleate (MK-801), a selective noncompetitive NMDA antagonist, did not alter kainate-induced changes in firing rate and firing pattern, which indicated that kainate-induced increases in burst-firing were not dependent on concomitant NMDA receptor activation by endogenous excitatory amino acid.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Dopamine/physiology , Neurons/physiology , Neurons/ultrastructure , Receptors, Amino Acid/classification , Receptors, Amino Acid/physiology , Substantia Nigra/physiology , Substantia Nigra/ultrastructure , Action Potentials/drug effects , Animals , Electrophysiology , Glutamates/pharmacology , Glutamic Acid , Iontophoresis , Kainic Acid/pharmacology , Male , N-Methylaspartate/pharmacology , Neurons/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Amino Acid/drug effects , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/physiology , Substantia Nigra/drug effects , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacologyABSTRACT
Extracellular single-unit recording and microiontophoretic techniques were used to determine the effects of ketamine-anesthesia on N-methyl-D-aspartate (NMDA)-induced excitation of Type I nucleus accumbens neurons. NMDA increased the firing rate of most neurons in this preparation. Thus, it may be concluded that ketamine-anesthesia does not result in blockade of central NMDA receptors. The excitation caused by NMDA was readily reversed in all cases by co-iontophoresis of MK 801, but was generally unaffected by coiontophoresis of ketamine. However, ketamine-anesthesia did significantly increase the current levels necessary for, and limited the magnitude of, NMDA-induced activation of these cells (as compared to urethane-anesthetized rats), suggesting that ketamine is not without effect on NMDA-receptors in vivo.
Subject(s)
Ketamine , N-Methylaspartate/pharmacology , Neurons/drug effects , Neurons/physiology , Nucleus Accumbens/drug effects , Nucleus Accumbens/physiology , Anesthesia , Animals , Dizocilpine Maleate/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Electrophysiology , Iontophoresis , Male , Rats , Rats, Sprague-DawleyABSTRACT
Further evaluation of the effects of BMY 14802 on dopamine (DA) neuronal activity in the rat substantia nigra pars compacta (A9) was conducted with single-unit recording and microiontophoresis in anesthetized rats. Microiontophoretic administration of BMY 14802 (sigma, serotonin (5-HT)-1A and alpha-1 adrenoceptor ligand) had no effect on DA neurons. Microiontophoretic administration of (+)-3-PPP (weak D2 agonist with high affinity for sigma receptors) and quinpirole (D2/D3 agonist) inhibited A9 DA neuronal activity. Co-iontophoresis or i.v. pretreatment with BMY 14802 had no effect on the current-response curves for the effects of microiontophoretic (+)-3-PPP or quinpirole on A9 DA neurons. Co-iontophoretic administration of (-)-sulpiride, a selective D2 antagonist, blocked the inhibitory effects of microiontophoretic (+)-3-PPP. The effects of BMY 14802 (0.25-8 mg/kg, i.v.) on DA neurons (increased firing rate, increased burst-firing, reduced regularity of firing pattern) were not altered by acute brain hemitransection, but were blocked by pretreatment with NAN-190, an antagonist of 5-HT-1A and alpha-1 receptors. The alpha-1 receptor antagonist, prazosin, did not block these effects of BMY 14802. In conclusion, the effects of BMY 14802 on DA neuronal firing rate and firing pattern are indirect, perhaps due in part to the occupation of 5-HT-1A receptors.
Subject(s)
Dopamine/physiology , Neurons/drug effects , Pyrimidines/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Dopamine Agents/pharmacology , Ergolines/pharmacology , Injections, Intravenous , Iontophoresis , Male , Neurons/physiology , Piperidines/pharmacology , Quinpirole , Rats , Rats, Sprague-Dawley , Serotonin Antagonists/pharmacology , Stereoisomerism , Sulpiride/pharmacologyABSTRACT
Iontophoresis and single-unit extracellular recording techniques were utilized to study the effects of in utero ethanol administration on nigrostriatal dopaminergic (NSDA) neurons in adult rats. Pregnant Sprague-Dawley rats consumed an ethanol-containing liquid diet providing 0%, 17.5%, or 35% ethanol-derived calories (EDC) from gestation day 8 until parturition. A separate group was fed standard rat chow as an ad lib, diet control. The dose-response curves of intravenously administered apomorphine on the spontaneous activity of NSDA neurons were shifted to the right in animals exposed to a liquid diet containing 17.5% or 35% EDC compared to 0% EDC or ad lib. control groups. The responsiveness of NSDA neurons to microiontophoretic application of the D-2 DA receptor agonist, quinpirole, was not altered following in utero ethanol exposure. These results suggest that in utero ethanol exposure may produce a down-regulation in the function of DA receptors distinct from the somatodendritic impulse-regulating D-2 autoreceptors. The firing pattern of NSDA neurons was also found to be altered after in utero ethanol exposure. There was a dissociation between the firing rate and burst activity in neurons that displayed burst-firing patterns in animals with in utero ethanol exposure. These observations agree with biochemical and behavioral studies that in utero ethanol exposure produces a long-lasting effect on the development of electrophysiological and pharmacological characteristics of midbrain DA systems in adulthood.
Subject(s)
Corpus Striatum/physiology , Ethanol/pharmacology , Neurons/physiology , Prenatal Exposure Delayed Effects , Substantia Nigra/physiology , Animals , Apomorphine/pharmacology , Corpus Striatum/cytology , Corpus Striatum/drug effects , Dopamine/metabolism , Electrophysiology , Ergolines/pharmacology , Female , Iontophoresis , Neurons/drug effects , Neurons/metabolism , Pregnancy , Quinpirole , Rats , Rats, Sprague-Dawley , Substantia Nigra/cytology , Substantia Nigra/drug effectsABSTRACT
The effect of acute withdrawal, after repeated ethanol administration, on the electrophysiological activity of dopamine (DA) neurons in the ventral tegmental area was studied. Male rats received a 10-day treatment of ethanol at 4 g/kg, twice daily via intragastric intubation. In animals treated with ethanol, the number of spontaneously active DA neurons, determined with the cells-per-track population sampling technique, was significantly reduced (ethanol group = 0.70 +/- 0.10; control group = 1.49 +/- 0.18). I.V. apomorphine (20-64 micrograms/kg) reversed the reduced number of spontaneously active DA neurons (1.30 +/- 0.14) to near control levels. 'Silent' DA neurons could also be induced to fire by microiontophoretic application of GABA. These results suggest that the reduction in the number of spontaneously active DA neurons was due to the induction of tonic depolarization-inactivation on these neurons.
Subject(s)
Alcoholism/pathology , Dopamine/physiology , Ethanol/pharmacology , Neurons/drug effects , Substance Withdrawal Syndrome/pathology , Ventral Tegmental Area/drug effects , Animals , Male , Membrane Potentials/drug effects , Rats , Rats, Sprague-Dawley , Ventral Tegmental Area/pathologyABSTRACT
Two isoforms of the D2 dopamine receptor exist, termed D2 short (D2s) and D2 long, which differ by the presence or absence of 29 amino acids. To examine the possible coupling of the D2s isoform to voltage-dependent K+ current, NG108-15 cells that were transfected with and stably express this isoform were studied using whole-cell patch-clamp techniques. In transfected, but not untransfected, cells dopamine and quinpirole (QUIN) reduced the normally observed peak outward K+ current, and this effect was abolished by the D2 antagonist sulpiride but not by the alpha 2-adrenergic receptor antagonist idazoxan or the D1 antagonist (R)-(+)-SCH-23380. The D1 receptor agonist SKF 38393 had no effect. QUIN-induced inhibition of K+ current was prevented by loading the cells with the Ca(2+)-chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, suggesting a critical role for intracellular Ca2+ mobilization. In contrast, reduction of the concentration of extracellular Ca2+ and inclusion of the Ca2+ channel blocker cobalt did not modify the reduction of K+ current produced by stimulation of D2s receptors. A critical role for intracellular calcium mobilization in the observed effects was further supported by the observation that increases in cytosolic Ca2+ produced by thapsigargin mimicked the effect of QUIN, whereas intracellular ryanodine, which blocks Ca2+ mobilization, abolished the QUIN responsiveness. Finally, the effect of D2S activation on K+ current was not modified by pretreatment of the cells with pertussis toxin. These results suggest that the D2s dopamine receptor expressed in NG108-15 cells inhibits the activity of native K+ current via a mechanism that is dependent upon the mobilization of intracellular Ca2+ and does not involve a pertussis toxin-sensitive G protein.
Subject(s)
Neurons/physiology , Potassium Channels/physiology , Receptors, Dopamine D2/physiology , Calcium/metabolism , Dopamine/pharmacology , Ergolines/pharmacology , GTP-Binding Proteins/drug effects , GTP-Binding Proteins/physiology , Glioma , Hybrid Cells , Membrane Potentials/drug effects , Membrane Potentials/physiology , Neuroblastoma , Neurons/drug effects , Pertussis Toxin , Potassium Channels/drug effects , Quinpirole , Receptors, Dopamine D2/drug effects , Recombinant Proteins , Tumor Cells, Cultured , Virulence Factors, Bordetella/pharmacologyABSTRACT
Acute and repeated administration of antipsychotic drugs produce distinctive profiles of electrophysiological effects on the population activity of midbrain dopaminergic (DA) neurons which correlate with their clinical effects. Sigma receptors have been hypothesized to be involved in psychosis and in the efficacy of antipsychotic drugs, but little is known about the effects of repeated treatment with sigma ligands on the activity of midbrain DA neuronal populations. In the present study, the cells-per-track cell-sampling method was used to evaluate the effects of 3 sigma ligands on the numbers of spontaneously active A9 and A10 DA neurons in chloral hydrate-anesthetized rats. One-hour pretreatment with either (+)-pentazocine (10 mg/kg, i.p.), DTG (2 mg/kg, i.p.), or JO 1784 (1 or 10 mg/kg, s.c.) did not alter the number of spontaneously active DA neurons encountered per electrode track. Repeated treatment (21 daily injections) with (+)-pentazocine (1 or 10 mg/kg) or DTG (0.2 or 2 mg/kg) increased the number of A10 DA cells per track; JO 1784 (10 mg/kg but not 1 mg/kg) moderately decreased the number of active A9 DA cells and increased the firing rate of A10 DA neurons. The effect of JO 1784 on A9 DA neurons was not due to depolarization inactivation. The effects of all 3 sigma ligands differ from those of antipsychotic drugs, all of which inactivate A10 DA neurons after repeated treatment. Clinical studies are necessary to determine if selective sigma ligands will provide a novel alternative to DA antagonists in the treatment of psychosis.
Subject(s)
Dopamine/metabolism , Mesencephalon/drug effects , Mesencephalon/metabolism , Neurons/physiology , Receptors, sigma/metabolism , Animals , Cinnamates/pharmacology , Cyclopropanes/pharmacology , Guanidines/pharmacology , Ligands , Male , Mesencephalon/cytology , Neurons/drug effects , Neurons/metabolism , Pentazocine/pharmacology , Rats , Rats, Sprague-Dawley , Time FactorsABSTRACT
The effects of repeated amphetamine treatment on single antidromically identified nigrostriatal dopamine-containing (NSDA) neurons were evaluated in rats. The inhibitory potency and efficacy of dopamine (DA) agonists on NSDA neuron spontaneous discharge rate were examined after amphetamine treatment. Repeated amphetamine treatment (14 days, 1 or 6 mg/kg/day i.p.) dose-dependently decreased the sensitivity of NSDA neurons to the inhibitory effects of the i.v. administered quinpirole. The amphetamine-induced alteration in sensitivity to apomorphine and quinpirole was abolished by acute hemitransection of the forebrain/midbrain connections. No change in the responsiveness or sensitivity of NSDA neurons to the inhibitory effects of iontophoretically applied DA was detected after amphetamine treatment for 14 days (4 or 6 mg/kg/day) or 28 days (6 mg/kg/day). These results suggest that these amphetamine regimens alter the sensitivity/responsiveness of forebrain DA receptors but not NSDA cell somatodendritic DA autoreceptors in a dose-dependent manner.
Subject(s)
Corpus Striatum/drug effects , Dextroamphetamine/pharmacology , Dopamine Agents/pharmacology , Prosencephalon/physiology , Receptors, Dopamine/drug effects , Substantia Nigra/drug effects , Animals , Apomorphine/pharmacology , Corpus Striatum/physiology , Dopamine/analysis , Dose-Response Relationship, Drug , Ergolines/pharmacology , Male , Quinpirole , Rats , Rats, Sprague-Dawley , Substantia Nigra/physiologyABSTRACT
The effects of i.v. administration of the noncompetitive NMDA receptor antagonists, phencyclidine and MK-801, and the sigma receptor ligand, 1,3-di(2-tolyl)guanidine (DTG), on the firing rates of non-dopaminergic mid brain neurons were evaluated in chloral hydrate-anesthetized rats. Phencyclidine and MK-801 inhibited the activity of putative gamma-aminobutyric acid (GABA)-containing interneurons identified by their response to foot-pinch. DTG did not significantly alter neuronal activity. These results suggest that the reported excitatory effects of non-competitive NMDA receptor antagonists on dopamine neuronal activity are due, in part, to disinhibition secondary to the inhibition of interneuron activity.
Subject(s)
Dizocilpine Maleate/pharmacology , Guanidines/pharmacology , Mesencephalon/drug effects , Neurons/drug effects , Phencyclidine/pharmacology , Action Potentials/drug effects , Animals , Dizocilpine Maleate/administration & dosage , Dose-Response Relationship, Drug , Injections, Intravenous , Male , Mesencephalon/cytology , Phencyclidine/administration & dosage , Rats , Rats, Sprague-Dawley , Receptors, sigma/drug effectsABSTRACT
Standard, extracellular single-unit recording techniques were used to examine the electrophysiological and pharmacological responsiveness of midbrain dopamine (DA) neurons to selected, ascending afferent inputs. Sciatic nerve stimulation-induced inhibition of nigrostriatal DA (NSDA) neurons was blocked by both PCPA (5-HT synthesis inhibitor) and 5,7-DHT (5-HT neurotoxin), suggesting mediation by a serotonergic (5-HT) system. Direct stimulation of the dorsal raphe (which utilizes 5-HT as a neurotransmitter and inhibits slowly firing NSDA neurons) inhibited all mesoaccumbens DA (MADA) neurons tested. Paradoxically, DPAT, a 5-HT1A agonist which inhibits 5-HT cell firing, enhanced sciatic nerve stimulation-induced inhibition of NSDA neurons. MADA neurons were not inhibited by sciatic nerve stimulation and, therefore, could not be tested in this paradigm. In contrast to the dorsal raphe, electrical stimulation of the pedunculopontine tegmental nucleus preferentially excited slowly firing NSDA and MADA neurons. Thus, both excitatory and inhibitory ascending afferents influence the activity of midbrain DA neurons, and intact 5-HT systems are necessary for sciatic nerve stimulation to alter DA cell activity. However, the role that 5-HT plays in mediating peripheral sensory input remains unclear.
Subject(s)
Dopamine/physiology , Mesencephalon/physiology , Neurons, Afferent/physiology , Neurons/physiology , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , 5,7-Dihydroxytryptamine/pharmacology , Animals , Electric Stimulation , Fenclonine/pharmacology , Injections, Intravenous , Male , Mesencephalon/cytology , Nucleus Accumbens/cytology , Nucleus Accumbens/physiology , Piperazines/pharmacology , Pons/physiology , Raphe Nuclei/cytology , Raphe Nuclei/physiology , Rats , Rats, Sprague-Dawley , Sciatic Nerve/physiology , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Substantia Nigra/cytology , Substantia Nigra/physiologyABSTRACT
The electrophysiological effects of the non-competitive N-methyl-D-aspartate (NMDA) antagonist (+)-MK-801 (MK-801) on nigrostriatal and mesoaccumbal dopaminergic (DA) neurons were evaluated in chloral hydrate-anesthetized rats. MK-801 (0.05-3.2 mg/kg, i.v.) stimulated the firing rates of 14 (74%) of 19 nigrostriatal DA (NSDA) neurons and all 16 mesoaccumbal DA (MADA) neurons tested. Stimulatory effects of the drug were more prominent on MADA neurons. Interspike interval analysis revealed that MK-801 also regularized DA neuronal firing pattern. Acute brain hemitransection between the midbrain and forebrain attenuated the stimulatory effects of MK-801 on firing rate and blocked the effects on firing pattern. Similar to MK-801, hemitransection itself increased NSDA and MADA cell firing rates and regularized firing pattern. Both i.v. and iontophoretic MK-801 blocked the excitatory effects of iontophoretic NMDA but did not affect excitations caused by the non-NMDA glutamatergic receptor agonists quisqualate and kainate. Iontophoretic MK-801 had no effect alone. These results suggest that the excitatory effects of i.v. MK-801 on DA neuronal activity are not due to direct actions on DA neurons. Glutamatergic projections originating anterior to the hemitransection appear to play a role in the effects of MK-801 on DA neuronal activity.
Subject(s)
Corpus Striatum/drug effects , Dizocilpine Maleate/pharmacology , Dopamine/physiology , Neurons/drug effects , Nucleus Accumbens/drug effects , Substantia Nigra/drug effects , Animals , Corpus Striatum/cytology , Evoked Potentials/drug effects , Injections, Intravenous , Male , Nucleus Accumbens/cytology , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Substantia Nigra/cytologyABSTRACT
The effects of acute i.v. administration of several sigma ligands on the single-unit activity of nigrostriatal and mesoaccumbal dopaminergic (DA) neurons were evaluated in chloral hydrate-anesthetized rats. DTG (1,3-di(o-tolyl)guanidine) did not alter DA neuronal activity at nontoxic doses and JO 1784 [(+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethylbut-3-en-1-+ ++ylamine] was inactive. (+)-Pentazocine was more effective in increasing mesoaccumbal vs. nigrostriatal DA cell firing rates. BMY 14802(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine-but anol) dose-dependently increased DA cell firing rate in both populations. The inhibition of nigrostriatal DA cell firing rate by (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [(+)-3-PPP] was reversed by (-)-eticlopride and (+)-but not (-)-butaclamol, which supports previous evidence that (+)-3-PPP-induced inhibition is due to the DA agonist properties of the drug. From what is known of the pharmacological properties of these compounds, it is concluded that acute sigma receptor occupation does not markedly alter the firing rate of DA neurons. The dose-response curve for inhibition of nigrostriatal DA neuronal activity by the D2 DA agonist, quinpirole, was shifted to the right tenfold by BMY 14802 pretreatment (8 mg/kg, i.v.) and twofold by (+)-pentazocine (8 mg/kg, i.v.), but was not changed by DTG (2 mg/kg, i.v.). It is concluded that the marked effects of certain sigma ligands on DA cell electrophysiology are likely due to their non-sigma properties.
Subject(s)
Caudate Nucleus/physiology , Dopamine/physiology , Ligands , Neurons/physiology , Putamen/physiology , Receptors, Opioid/metabolism , Substantia Nigra/physiology , Animals , Caudate Nucleus/cytology , Caudate Nucleus/drug effects , Electrophysiology , Male , Neurons/drug effects , Putamen/cytology , Putamen/drug effects , Rats , Rats, Inbred Strains , Receptors, sigma , Substantia Nigra/cytology , Substantia Nigra/drug effectsABSTRACT
Dopamine (DA)-containing neurons in primary dissociated cell cultures derived from the embryonic mouse mesencephalon (day E13) were studied by histochemical and electrophysiological techniques. DA neurons exhibited two distinct morphologies, fusiform and multipolar, tended to reside in groups and organize dendrites into common fascicles. While these neurons expressed the cell-surface marker acetylcholinesterase, the presence of this enzyme could not be used to identify DA neurons unequivocally, since it was also observed in nondopaminergic cells. Neurons were therefore identified as DA by their distinct morphology, and this identification was validated with a double-labeling procedure that entailed the intracellular deposition of a fluorescent dye (Lucifer yellow or ethidium bromide), followed by processing for tyrosine hydroxylase immunocytochemistry. DA neurons identified in this manner were observed to have resting membrane potentials between -50 and -75 mV, input resistances of 50-360 M omega, and membrane time constants of 4.1-14.1 msec. Forty-seven percent of these cells displayed spontaneous activity that was irregular in nature and often contained bursts (burst length was between two and six action potentials). The DA neurons displayed a variety of ionic conductances, including (1) a Na+ conductance (gNa) that underlies the action potential, (2) Ca2+ conductances (gCa) that mediate the nonsomatic low- and high-threshold spikes observed, and (3) at least three K+ conductances (gK). Voltage-clamp analysis revealed several distinct transmembrane ionic currents, including (1) a large, rapidly inactivating tetrodotoxin-sensitive inward Na+ current (INa), (2) a 4-aminopyridine-sensitive, transient early outward K+ current that required a conditioning hyperpolarization of the membrane to be activated by a subsequent depolarization (A-current, IA), (3) a slowly developing inward current that was seen only after a conditioning hyperpolarization of the membrane and that was dependent on the presence of external Ca2+ ions (ICa), and (4) a late-onset, noninactivating K+ current. Between 25% and 54% of the late-onset K+ current was Ca(2+)-dependent and was not affected by tetraethylammonium ions. This current was termed IAHP. The remaining current was not sensitive to changes in the extracellular Ca2+ concentration but was blocked by external tetraethylammonium. This current was termed IK. The direct pressure application of DA (1-200 microM) onto the soma dose-dependently hyperpolarized these neurons; this effect was potentiated by the presence of the catecholamine reuptake blocker cocaine hydrochloride (10-200 microM). Under voltage-clamp conditions, DA was observed to increase IK significantly and had little effect on IAHP.(ABSTRACT TRUNCATED AT 400 WORDS)